Section 439.Sec. 4.1 - NEW1. Except as otherwise provided in subsection 2, a record of a patient in the system for the reporting of information on sickle cell disease and its variants established pursuant to NRS 439.4929 is confidential.2. The Chief Medical Officer may disclose information from the record of a patient in the system for the reporting of information on sickle cell disease and its variants established pursuant to NRS 439.4929 to: (a) The patient to whom the record pertains and any legal representative of such a patient;(b) The hospital, medical laboratory, other facility or provider of health care who reported the information or from whom the record was abstracted;(c) Any other hospital, medical laboratory, other facility or provider of health care that participated in treating the patient or any registry associated with such a hospital, medical laboratory, other facility or provider of health care;(d) A registry maintained by another governmental entity in the United States that enters into an agreement with the Chief Medical Officer concerning the use of the information that ensures the confidentiality of the information; or(e) A qualified researcher whom the Division determines will conduct valid scientific research with the information and who: (1) Enters into an agreement with the Chief Medical Officer concerning the use of the information that ensures the confidentiality of the information; and(2) Pays a fee of $200 or the actual cost to the Division of providing the information to the researcher, whichever is greater.Nev. Admin. Code § 439.Sec. 4.1
Added to NAC by Bd. of Health by R107-22A, eff. 7/31/2023NRS 439.150, 439.200, 439.4931, 439.4935